These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3140436)

  • 1. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
    Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
    Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune-dependence of chemotherapy in experimental schistosomiasis.
    Doenhoff MJ
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
    Fallon PG; Doenhoff MJ
    Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-dependent chemotherapy of schistosomiasis.
    Fallon PG; Cooper RO; Probert AJ; Doenhoff MJ
    Parasitology; 1992; 105 Suppl():S41-8. PubMed ID: 1308928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
    Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
    Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.
    Li HJ; Xu FL; Wang YH; Yi ZJ; Wang W
    Parasitol Res; 2014 Jan; 113(1):239-41. PubMed ID: 24146209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel versus praziquantel associated with immunomodulators in mice infected with schistosoma mansoni: A systematic review and meta-analysis.
    Silva JCS; Bernardes MVAS; Melo FL; Sá MPBO; Carvalho BM
    Acta Trop; 2020 Apr; 204():105359. PubMed ID: 31987779
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
    Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
    Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
    El-Moslemany RM; Eissa MM; Ramadan AA; El-Khordagui LK; El-Azzouni MZ
    Acta Trop; 2016 Jul; 159():142-8. PubMed ID: 27039667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
    Brindley PJ; Strand M; Norden AP; Sher A
    Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: enhanced efficacy of praziquantel treatment in immune mice.
    Flisser A; Delgado VS; McLaren DJ
    Parasite Immunol; 1989 Jul; 11(4):319-28. PubMed ID: 2506506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.
    Doenhoff MJ; Modha J; Lambertucci JR
    Immunology; 1988 Dec; 65(4):507-10. PubMed ID: 3146547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.